Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

Human pathology·2026
Same author

Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma.

Blood advances·2026
Same author

Cytogenetic and Molecular Analysis of a "Double-Hit" RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia.

Genes, chromosomes & cancer·2026
Same author

Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study From the BCR::ABL1 Pathology Group.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Research progress and clinical application of functional magnetic resonance imaging in otolaryngology-head and neck diseases.

Frontiers in neurology·2026
Same author

Distinct Pattern of Atypical Megakaryocytes in VEXAS Syndrome.

International journal of laboratory hematology·2026

Related Experiment Video

Updated: Jul 31, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.0K

Myeloid sarcoma: An overview.

Maximiliano Ramia de Cap1, Weina Chen2

  • 1North Bristol NHS Trust, Southmead Hospital, Pathology Sciences Building, Westbury on Trym, Bristol BS10 5NB, UK.

Seminars in Diagnostic Pathology
|May 6, 2023
PubMed
Summary

Myeloid Sarcoma (MS) is a rare, heterogeneous hematological malignancy. Understanding its pathogenesis and treatment is crucial for improving patient outcomes.

Keywords:
Acute myeloid leukemiaChemotherapyGeneticsImmunophenotypeMyeloid sarcomaPrognosisRadiotherapy

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K

Related Experiment Videos

Last Updated: Jul 31, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.0K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K
Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
06:33

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

1.3K

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Myeloid Sarcoma (MS) is a rare extramedullary tumor of myeloid blasts, presenting a significant diagnostic and therapeutic challenge due to its heterogeneity.
  • The rarity and heterogeneity of MS have impeded comprehensive understanding and research efforts.
  • Current diagnostic approaches involve tumor biopsy and bone marrow evaluation.

Purpose of the Study:

  • To provide a comprehensive overview of Myeloid Sarcoma.
  • To review the current understanding of MS pathogenesis, pathology, genetics, treatment, and prognosis.
  • To highlight the need for further research into MS pathogenesis and treatment response.

Main Methods:

  • Literature review of Myeloid Sarcoma.
  • Analysis of pathological and genetic findings in MS.
  • Synthesis of current treatment strategies and prognostic factors.

Main Results:

  • MS is a heterogeneous myeloid neoplasm requiring biopsy and bone marrow evaluation.
  • Treatment recommendations are similar to Acute Myeloid Leukemia (AML), with potential benefits from radiotherapy and targeted therapies.
  • Genetic profiling reveals abnormalities similar to AML, but organ homing mechanisms remain unclear.

Conclusions:

  • Further understanding of MS pathogenesis is essential for improving patient management and outcomes.
  • Investigating the mechanisms of organ-specific homing in MS is a critical area for future research.
  • Enhanced knowledge of MS pathogenesis and therapeutic responses will guide the development of novel treatment strategies.